Healios KK
TSE:4593

Watchlist Manager
Healios KK Logo
Healios KK
TSE:4593
Watchlist
Price: 288 JPY -8.57% Market Closed
Market Cap: 33.2B JPY

Wall Street
Price Targets

Price Targets Summary
Healios KK

Wall Street analysts forecast Healios KK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Healios KK is 657.9 JPY with a low forecast of 515.1 JPY and a high forecast of 756 JPY.

Lowest
Price Target
515.1 JPY
79% Upside
Average
Price Target
657.9 JPY
128% Upside
Highest
Price Target
756 JPY
163% Upside
Healios KK Competitors:
Price Targets
LTRN
Lantern Pharma Inc.
467% Upside
ORGO
Organogenesis Holdings Inc
80% Upside
MRSN
Mersana Therapeutics Inc
19% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
24% Upside
URGN
Urogen Pharma Ltd
65% Upside
2126
JW (Cayman) Therapeutics Co Ltd
102% Upside
VCYT
Veracyte Inc
15% Upside
REGN
Regeneron Pharmaceuticals Inc
7% Upside

Revenue
Forecast

Revenue Estimate
Healios KK

For the last 10 years the compound annual growth rate for Healios KK's revenue is 7%. The projected CAGR for the next 3 years is 106%.

7%
Past Growth
106%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Healios KK

Operating Income forecast
is not available for
Healios KK

Net Income
Forecast

Net Income Estimate
Healios KK

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Healios KK's stock price target?
Price Target
657.9 JPY

According to Wall Street analysts, the average 1-year price target for Healios KK is 657.9 JPY with a low forecast of 515.1 JPY and a high forecast of 756 JPY.

What is Healios KK's Revenue forecast?
Projected CAGR
106%

For the last 10 years the compound annual growth rate for Healios KK's revenue is 7%. The projected CAGR for the next 3 years is 106%.

Back to Top